| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.912 | 0.002 | 0.947 | Carbonic anhydrase XV inhibitor | 0.321 0.006 DBMET01338 0.843 0.002 DBMET01344 0.947 0.001 DBMET01349 0.349 0.005 DBMET01340 0.279 0.009 DBMET01342 0.885 0.002 DBMET01346 0.921 0.001 DBMET01347 0.349 0.005 DBMET01341 | DBMET01349 | |
| 0.846 | 0.003 | 0.846 | Cyclooxygenase 1 inhibitor | 0.709 0.004 DBMET01338 0.844 0.003 DBMET01344 0.782 0.003 DBMET01349 0.523 0.005 DBMET01340 0.733 0.004 DBMET01342 0.728 0.004 DBMET01346 0.804 0.003 DBMET01347 0.587 0.004 DBMET01341 | ||
| 0.815 | 0.003 | 0.815 | Cyclooxygenase inhibitor | 0.782 0.003 DBMET01338 0.808 0.003 DBMET01344 0.718 0.003 DBMET01349 0.47 0.005 DBMET01340 0.794 0.003 DBMET01342 0.682 0.004 DBMET01346 0.744 0.003 DBMET01347 0.517 0.004 DBMET01341 | ||
| 0.746 | 0.003 | 0.776 | Non-steroidal antiinflammatory agent | 0.295 0.029 DBMET01338 0.623 0.004 DBMET01344 0.776 0.003 DBMET01349 0.254 0.041 DBMET01340 0.214 0.061 DBMET01342 0.659 0.004 DBMET01346 0.633 0.004 DBMET01347 0.365 0.018 DBMET01341 | DBMET01349 | |
| 0.735 | 0.002 | 0.867 | Carbonic anhydrase VI inhibitor | 0.252 0.009 DBMET01338 0.65 0.003 DBMET01344 0.867 0.002 DBMET01349 0.195 0.014 DBMET01340 0.202 0.013 DBMET01342 0.655 0.003 DBMET01346 0.801 0.002 DBMET01347 0.195 0.014 DBMET01341 | DBMET01349 | |
| 0.712 | 0.003 | 0.712 | Cyclooxygenase 2 inhibitor | 0.672 0.003 DBMET01338 0.691 0.003 DBMET01344 0.608 0.003 DBMET01349 0.377 0.007 DBMET01340 0.67 0.003 DBMET01342 0.581 0.004 DBMET01346 0.624 0.003 DBMET01347 0.407 0.005 DBMET01341 | ||
| 0.67 | 0.003 | 0.832 | Carbonic anhydrase XIII inhibitor | 0.212 0.013 DBMET01338 0.565 0.003 DBMET01344 0.832 0.002 DBMET01349 0.158 0.02 DBMET01340 0.164 0.019 DBMET01342 0.603 0.003 DBMET01346 0.718 0.002 DBMET01347 0.158 0.02 DBMET01341 | DBMET01349 | |
| 0.663 | 0.038 | 0.839 | Antiinflammatory | 0.825 0.012 DBMET01338 0.711 0.029 DBMET01344 0.657 0.039 DBMET01349 0.839 0.01 DBMET01342 0.459 0.106 DBMET01346 0.7 0.031 DBMET01347 0.63 0.046 DBMET01341 | DBMET01342 | |
| 0.485 | 0.002 | 0.528 | Carbonic anhydrase VB inhibitor | 0.189 0.005 DBMET01338 0.402 0.002 DBMET01344 0.528 0.002 DBMET01349 0.141 0.01 DBMET01340 0.148 0.009 DBMET01342 0.378 0.002 DBMET01346 0.423 0.002 DBMET01347 0.158 0.008 DBMET01341 | DBMET01349 | |
| 0.437 | 0.004 | 0.564 | MAP kinase kinase 10 inhibitor | 0.293 0.005 DBMET01338 0.564 0.003 DBMET01344 0.237 0.005 DBMET01349 0.327 0.005 DBMET01340 0.48 0.004 DBMET01342 0.117 0.015 DBMET01346 0.452 0.004 DBMET01347 0.327 0.005 DBMET01341 | DBMET01344 | |
| 0.424 | 0.004 | 0.432 | Carbonic anhydrase XII inhibitor | 0.248 0.006 DBMET01338 0.313 0.004 DBMET01344 0.432 0.004 DBMET01349 0.171 0.01 DBMET01342 0.335 0.004 DBMET01346 0.326 0.004 DBMET01347 0.177 0.01 DBMET01341 | DBMET01349 | |
| 0.416 | 0.004 | 0.702 | Potassium channel large-conductance Ca-activated activator | 0.702 0.002 DBMET01338 0.238 0.005 DBMET01344 0.375 0.004 DBMET01349 0.44 0.004 DBMET01340 0.67 0.002 DBMET01342 0.35 0.004 DBMET01346 0.229 0.005 DBMET01347 0.596 0.003 DBMET01341 | DBMET01338 | |
| 0.396 | 0.003 | 0.401 | Multidrug resistance-associated protein 1 inhibitor | 0.345 0.003 DBMET01338 0.247 0.005 DBMET01344 0.362 0.003 DBMET01349 0.401 0.003 DBMET01340 0.201 0.01 DBMET01342 0.253 0.005 DBMET01346 0.238 0.005 DBMET01347 0.401 0.003 DBMET01341 | DBMET01341 | |
| 0.395 | 0.003 | 0.509 | Carbonic anhydrase VII inhibitor | 0.048 0.03 DBMET01338 0.298 0.003 DBMET01344 0.509 0.002 DBMET01349 0.041 0.039 DBMET01340 0.329 0.003 DBMET01346 0.383 0.003 DBMET01347 0.189 0.005 DBMET01341 | DBMET01349 | |
| 0.389 | 0.003 | 0.448 | Carbonic anhydrase V inhibitor | 0.143 0.016 DBMET01338 0.339 0.003 DBMET01344 0.448 0.003 DBMET01349 0.099 0.027 DBMET01340 0.113 0.023 DBMET01342 0.315 0.003 DBMET01346 0.364 0.003 DBMET01347 0.146 0.015 DBMET01341 | DBMET01349 | |
| 0.37 | 0.003 | 0.37 | Bromodomain-containing protein 4 inhibitor | 0.337 0.003 DBMET01338 0.164 0.005 DBMET01344 0.281 0.004 DBMET01349 0.269 0.004 DBMET01340 0.168 0.005 DBMET01342 0.054 0.039 DBMET01346 0.132 0.008 DBMET01347 0.293 0.004 DBMET01341 | ||
| 0.369 | 0.004 | 0.369 | Carbonic anhydrase IX inhibitor | 0.209 0.008 DBMET01338 0.279 0.005 DBMET01344 0.349 0.004 DBMET01349 0.148 0.012 DBMET01342 0.279 0.005 DBMET01346 0.275 0.005 DBMET01347 0.081 0.026 DBMET01341 | ||
| 0.367 | 0.003 | 0.422 | Carbonic anhydrase VA inhibitor | 0.127 0.016 DBMET01338 0.301 0.003 DBMET01344 0.422 0.003 DBMET01349 0.09 0.03 DBMET01340 0.101 0.024 DBMET01342 0.28 0.003 DBMET01346 0.326 0.003 DBMET01347 0.125 0.017 DBMET01341 | DBMET01349 | |
| 0.363 | 0.005 | 0.363 | Cyclin-dependent kinase 3 inhibitor | 0.345 0.005 DBMET01344 0.333 0.006 DBMET01349 0.328 0.006 DBMET01346 0.328 0.006 DBMET01347 | ||
| 0.336 | 0.003 | 0.485 | Carbonic anhydrase XIV inhibitor | 0.051 0.032 DBMET01338 0.303 0.004 DBMET01344 0.485 0.003 DBMET01349 0.045 0.039 DBMET01342 0.341 0.003 DBMET01346 0.413 0.003 DBMET01347 0.15 0.005 DBMET01341 | DBMET01349 | |
| 0.321 | 0.01 | 0.321 | Protein kinase (CK1) delta inhibitor | 0.199 0.029 DBMET01344 0.206 0.027 DBMET01349 0.185 0.034 DBMET01346 0.159 0.048 DBMET01347 | ||
| 0.312 | 0.004 | 0.397 | Carbonic anhydrase inhibitor | 0.397 0.004 DBMET01338 0.257 0.005 DBMET01344 0.311 0.004 DBMET01349 0.328 0.004 DBMET01342 0.274 0.005 DBMET01346 0.258 0.005 DBMET01347 0.133 0.019 DBMET01341 | DBMET01338 | |
| 0.311 | 0.004 | 0.426 | Electrolyte absorption antagonist | 0.265 0.004 DBMET01344 0.227 0.005 DBMET01349 0.426 0.003 DBMET01346 0.187 0.01 DBMET01347 | DBMET01346 | |
| 0.296 | 0.005 | 0.459 | Carbonic anhydrase III inhibitor | 0.109 0.053 DBMET01338 0.319 0.005 DBMET01344 0.459 0.003 DBMET01349 0.111 0.051 DBMET01342 0.348 0.004 DBMET01346 0.448 0.004 DBMET01347 0.197 0.017 DBMET01341 | DBMET01349 | |
| 0.302 | 0.014 | 0.302 | Histone acetyltransferase inhibitor | 0.179 0.101 DBMET01338 0.21 0.055 DBMET01344 0.275 0.018 DBMET01349 0.187 0.089 DBMET01346 0.201 0.067 DBMET01347 | ||
| 0.288 | 0.025 | 0.456 | Diuretic | 0.199 0.044 DBMET01344 0.267 0.028 DBMET01349 0.456 0.01 DBMET01346 0.176 0.056 DBMET01347 0.252 0.03 DBMET01341 | DBMET01346 | |
| 0.305 | 0.065 | 0.567 | Aldehyde oxidase inhibitor | 0.306 0.065 DBMET01344 0.567 0.023 DBMET01349 0.464 0.038 DBMET01346 0.497 0.033 DBMET01347 | DBMET01349 | |
| 0.226 | 0.005 | 0.295 | Carbonic anhydrase II inhibitor | 0.295 0.004 DBMET01338 0.199 0.006 DBMET01344 0.216 0.005 DBMET01349 0.259 0.004 DBMET01342 0.211 0.005 DBMET01346 0.192 0.006 DBMET01347 0.076 0.027 DBMET01341 | DBMET01338 | |
| 0.228 | 0.032 | 0.228 | Protein kinase (CK1) inhibitor | 0.136 0.079 DBMET01344 0.147 0.07 DBMET01349 0.136 0.078 DBMET01346 0.12 0.091 DBMET01341 | ||
| 0.271 | 0.086 | 0.498 | Lipoxygenase inhibitor | 0.483 0.021 DBMET01338 0.301 0.071 DBMET01344 0.415 0.034 DBMET01349 0.498 0.019 DBMET01342 0.259 0.094 DBMET01346 0.411 0.035 DBMET01347 0.287 0.078 DBMET01341 | DBMET01342 | |
| 0.188 | 0.01 | 0.224 | MAP kinase 10 inhibitor | 0.089 0.042 DBMET01338 0.224 0.008 DBMET01344 0.105 0.032 DBMET01349 0.085 0.046 DBMET01340 0.119 0.025 DBMET01342 0.073 0.059 DBMET01346 0.142 0.017 DBMET01347 0.085 0.046 DBMET01341 | DBMET01344 | |
| 0.3 | 0.134 | 0.3 | Beta lactamase inhibitor | |||
| 0.259 | 0.1 | 0.259 | Nootropic | 0.185 0.18 DBMET01344 | ||
| 0.162 | 0.004 | 0.243 | Carbonic anhydrase IV inhibitor | 0.243 0.003 DBMET01338 0.133 0.004 DBMET01344 0.138 0.004 DBMET01349 0.184 0.003 DBMET01342 0.155 0.004 DBMET01346 0.117 0.005 DBMET01347 | DBMET01338 | |
| 0.191 | 0.033 | 0.191 | Sodium channel (voltage-gated) blocker | 0.137 0.066 DBMET01344 0.127 0.077 DBMET01349 0.106 0.102 DBMET01347 | ||
| 0.239 | 0.082 | 0.286 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.286 0.068 DBMET01349 0.155 0.136 DBMET01346 | DBMET01349 | |
| 0.226 | 0.071 | 0.226 | EphB2 antagonist | 0.211 0.08 DBMET01349 | ||
| 0.154 | 0.004 | 0.178 | Purinergic P2X4 antagonist | 0.079 0.007 DBMET01344 0.178 0.003 DBMET01349 0.071 0.009 DBMET01346 0.094 0.005 DBMET01347 0.117 0.004 DBMET01341 | DBMET01349 | |
| 0.184 | 0.039 | 0.184 | Sodium channel blocker | 0.107 0.102 DBMET01344 0.119 0.085 DBMET01349 | ||
| 0.147 | 0.004 | 0.147 | Bromodomain-containing protein 3 inhibitor | 0.098 0.005 DBMET01338 0.102 0.005 DBMET01349 0.109 0.005 DBMET01340 0.114 0.005 DBMET01341 | ||
| 0.26 | 0.118 | 0.333 | Sodium/bile acid cotransporter inhibitor | 0.272 0.105 DBMET01344 0.333 0.052 DBMET01349 0.317 0.065 DBMET01346 0.321 0.061 DBMET01347 0.332 0.053 DBMET01341 | DBMET01349 | |
| 0.148 | 0.01 | 0.151 | Carbonic anhydrase I inhibitor | 0.076 0.026 DBMET01338 0.135 0.012 DBMET01344 0.134 0.012 DBMET01349 0.068 0.03 DBMET01342 0.151 0.01 DBMET01346 0.124 0.013 DBMET01347 | DBMET01346 | |
| 0.177 | 0.039 | 0.188 | CF transmembrane conductance regulator agonist | 0.174 0.042 DBMET01344 0.188 0.029 DBMET01349 0.158 0.062 DBMET01346 0.183 0.034 DBMET01347 | DBMET01349 | |
| 0.232 | 0.099 | 0.234 | Transcription factor STAT3 inhibitor | 0.203 0.13 DBMET01344 0.234 0.097 DBMET01349 0.23 0.101 DBMET01346 0.203 0.13 DBMET01347 | DBMET01349 | |
| 0.144 | 0.011 | 0.144 | Bromodomain-containing protein 2 inhibitor | 0.08 0.078 DBMET01338 0.109 0.031 DBMET01349 0.088 0.059 DBMET01340 0.138 0.013 DBMET01341 | ||
| 0.158 | 0.04 | 0.158 | Pregnane X receptor agonist | 0.141 0.072 DBMET01344 0.152 0.049 DBMET01349 0.131 0.096 DBMET01346 0.136 0.084 DBMET01347 | ||
| 0.146 | 0.028 | 0.146 | Protein kinase C mu inhibitor | 0.104 0.053 DBMET01344 0.13 0.036 DBMET01349 0.096 0.061 DBMET01346 0.102 0.055 DBMET01347 | ||
| 0.115 | 0.007 | 0.164 | Heat shock protein 90 beta antagonist | 0.059 0.041 DBMET01344 0.164 0.004 DBMET01349 0.059 0.041 DBMET01346 0.079 0.022 DBMET01347 | DBMET01349 | |
| 0.16 | 0.053 | 0.191 | Alkaline phosphatase inhibitor | 0.136 0.07 DBMET01344 0.191 0.037 DBMET01349 0.168 0.049 DBMET01346 0.16 0.054 DBMET01347 | DBMET01349 | |
| 0.144 | 0.043 | 0.144 | Cyclin-dependent kinase 1 inhibitor | 0.117 0.056 DBMET01344 0.119 0.055 DBMET01349 0.083 0.08 DBMET01346 0.105 0.063 DBMET01347 | ||
| 0.102 | 0.008 | 0.164 | Nitric oxide donor | 0.158 0.002 DBMET01338 0.111 0.005 DBMET01344 0.096 0.011 DBMET01349 0.075 0.027 DBMET01340 0.164 0.002 DBMET01342 0.094 0.012 DBMET01346 0.106 0.006 DBMET01347 0.084 0.019 DBMET01341 | DBMET01342 | |
| 0.213 | 0.12 | 0.236 | Transcription factor STAT inhibitor | 0.18 0.167 DBMET01344 0.222 0.11 DBMET01349 0.236 0.097 DBMET01346 0.187 0.156 DBMET01347 | DBMET01346 | |
| 0.089 | 0.007 | 0.093 | CXC chemokine 1 receptor antagonist | 0.077 0.009 DBMET01344 0.093 0.006 DBMET01349 0.064 0.017 DBMET01346 0.079 0.009 DBMET01347 0.052 0.034 DBMET01341 | DBMET01349 | |
| 0.182 | 0.1 | 0.182 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.126 | 0.046 | 0.126 | Sphingosine 1-phosphate receptor 2 agonist | 0.114 0.066 DBMET01344 0.124 0.049 DBMET01349 0.115 0.064 DBMET01346 0.114 0.065 DBMET01347 | ||
| 0.085 | 0.005 | 0.122 | Dihydropteroate synthase inhibitor | 0.068 0.009 DBMET01344 0.086 0.005 DBMET01349 0.095 0.005 DBMET01346 0.064 0.01 DBMET01347 0.122 0.004 DBMET01341 | DBMET01341 | |
| 0.241 | 0.162 | 0.245 | GABA C receptor rho-3 antagonist | 0.245 0.158 DBMET01349 0.234 0.169 DBMET01340 0.234 0.169 DBMET01341 | DBMET01349 | |
| 0.146 | 0.071 | 0.168 | MAP kinase kinase 4 inhibitor | 0.147 0.068 DBMET01344 0.168 0.035 DBMET01349 0.149 0.063 DBMET01346 0.166 0.038 DBMET01347 | DBMET01349 | |
| 0.096 | 0.024 | 0.204 | Sphingosine 1-phosphate receptor antagonist | 0.089 0.031 DBMET01344 0.094 0.026 DBMET01349 0.1 0.021 DBMET01346 0.084 0.038 DBMET01347 0.204 0.004 DBMET01341 | DBMET01341 | |
| 0.148 | 0.077 | 0.212 | Heat shock protein 90 antagonist | 0.212 0.033 DBMET01349 0.122 0.109 DBMET01340 0.171 0.055 DBMET01341 | DBMET01349 | |
| 0.082 | 0.013 | 0.082 | Factor X inhibitor | 0.053 0.021 DBMET01344 0.04 0.026 DBMET01349 0.044 0.024 DBMET01346 | ||
| 0.09 | 0.022 | 0.09 | Carbonic anhydrase stimulant | 0.073 0.029 DBMET01344 0.066 0.035 DBMET01349 0.085 0.023 DBMET01346 | ||
| 0.093 | 0.026 | 0.093 | Nav1.7 sodium channel blocker | 0.063 0.054 DBMET01344 | ||
| 0.08 | 0.014 | 0.147 | Sphingosine 1-phosphate receptor 1 antagonist | 0.094 0.01 DBMET01344 0.077 0.015 DBMET01349 0.108 0.008 DBMET01346 0.08 0.014 DBMET01347 0.147 0.004 DBMET01341 | DBMET01341 | |
| 0.239 | 0.174 | 0.511 | 15-Lipoxygenase inhibitor | 0.364 0.092 DBMET01349 0.227 0.185 DBMET01347 0.511 0.038 DBMET01341 | DBMET01341 | |
| 0.074 | 0.012 | 0.074 | Carbonic anhydrase II stimulant | 0.066 0.017 DBMET01344 0.06 0.023 DBMET01349 0.068 0.015 DBMET01346 0.056 0.029 DBMET01347 | ||
| 0.179 | 0.118 | 0.376 | Platelet antagonist | 0.376 0.032 DBMET01344 0.172 0.124 DBMET01349 0.232 0.081 DBMET01342 0.252 0.071 DBMET01346 0.327 0.044 DBMET01347 0.246 0.074 DBMET01341 | DBMET01344 | |
| 0.205 | 0.143 | 0.212 | 5 Hydroxytryptamine uptake stimulant | 0.205 0.142 DBMET01344 0.199 0.155 DBMET01349 0.212 0.13 DBMET01346 0.201 0.149 DBMET01347 | DBMET01346 | |
| 0.109 | 0.048 | 0.474 | Potassium channel (Ca-activated) activator | 0.474 0.003 DBMET01338 0.134 0.034 DBMET01349 0.132 0.034 DBMET01340 0.31 0.005 DBMET01342 0.123 0.039 DBMET01346 0.397 0.004 DBMET01341 | DBMET01338 | |
| 0.182 | 0.124 | 0.219 | Peptidyltransferase inhibitor | 0.196 0.104 DBMET01344 0.211 0.086 DBMET01349 0.219 0.077 DBMET01346 0.202 0.096 DBMET01347 | DBMET01346 | |
| 0.129 | 0.073 | 0.131 | CC chemokine 6 receptor antagonist | 0.12 0.116 DBMET01338 0.131 0.067 DBMET01349 0.125 0.093 DBMET01346 | DBMET01349 | |
| 0.125 | 0.069 | 0.142 | MAP kinase kinase inhibitor | 0.142 0.056 DBMET01338 0.125 0.069 DBMET01344 0.139 0.058 DBMET01349 0.138 0.059 DBMET01342 0.131 0.064 DBMET01347 | DBMET01338 | |
| 0.155 | 0.101 | 0.424 | Platelet adhesion inhibitor | 0.176 0.084 DBMET01349 0.184 0.08 DBMET01340 0.424 0.009 DBMET01341 | DBMET01341 | |
| 0.083 | 0.031 | 0.083 | ZAP-70 protein tyrosine kinase inhibitor | 0.075 0.041 DBMET01344 0.072 0.046 DBMET01349 0.068 0.05 DBMET01346 0.068 0.051 DBMET01347 | ||
| 0.062 | 0.013 | 0.062 | Benzodiazepine inverse agonist | 0.051 0.025 DBMET01338 0.047 0.032 DBMET01344 0.048 0.029 DBMET01349 0.06 0.014 DBMET01340 0.06 0.014 DBMET01341 | ||
| 0.088 | 0.041 | 0.102 | CC chemokine 5 receptor agonist | 0.102 0.019 DBMET01349 0.082 0.057 DBMET01347 | DBMET01349 | |
| 0.065 | 0.022 | 0.065 | Factor Xa inhibitor | |||
| 0.079 | 0.037 | 0.083 | Sphingosine 1-phosphate receptor 4 agonist | 0.083 0.035 DBMET01344 0.066 0.048 DBMET01349 0.071 0.044 DBMET01346 0.06 0.054 DBMET01347 | DBMET01344 | |
| 0.07 | 0.028 | 0.07 | Cyclin H inhibitor | 0.059 0.041 DBMET01344 0.057 0.043 DBMET01349 0.052 0.051 DBMET01346 | ||
| 0.069 | 0.03 | 0.069 | Potassium channel Kv1.5 blocker | |||
| 0.051 | 0.013 | 0.065 | Kainate receptor agonist | 0.045 0.021 DBMET01344 0.044 0.022 DBMET01349 0.065 0.005 DBMET01346 | DBMET01346 | |
| 0.142 | 0.104 | 0.506 | Dual specificity phosphatase 3 inhibitor | 0.198 0.062 DBMET01344 0.175 0.077 DBMET01349 0.253 0.039 DBMET01346 0.209 0.056 DBMET01347 0.506 0.007 DBMET01341 | DBMET01341 | |
| 0.157 | 0.119 | 0.157 | Focal adhesion kinase 2 inhibitor | |||
| 0.078 | 0.042 | 0.083 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.083 0.032 DBMET01341 | DBMET01341 | |
| 0.093 | 0.068 | 0.104 | Phosphodiesterase 6D inhibitor | 0.101 0.049 DBMET01344 0.095 0.062 DBMET01349 0.089 0.078 DBMET01346 0.104 0.046 DBMET01347 | DBMET01347 | |
| 0.069 | 0.045 | 0.083 | Glutamate (mGluR7) antagonist | 0.063 0.058 DBMET01349 0.072 0.039 DBMET01340 0.083 0.024 DBMET01346 0.072 0.039 DBMET01341 | DBMET01346 | |
| 0.064 | 0.043 | 0.068 | Transcription factor RelA inhibitor | 0.068 0.033 DBMET01349 | DBMET01349 | |
| 0.069 | 0.049 | 0.069 | I kappa B kinase 1 inhibitor | |||
| 0.111 | 0.092 | 0.111 | Lck kinase inhibitor | |||
| 0.036 | 0.019 | 0.04 | Peroxisome proliferator-activated receptor delta antagonist | 0.034 0.021 DBMET01344 0.034 0.022 DBMET01349 0.032 0.026 DBMET01340 0.04 0.015 DBMET01346 0.031 0.028 DBMET01347 0.032 0.026 DBMET01341 | DBMET01346 | |
| 0.044 | 0.03 | 0.074 | Glutamate (mGluR group III) antagonist | 0.04 0.038 DBMET01344 0.074 0.009 DBMET01346 | DBMET01346 | |
| 0.04 | 0.028 | 0.043 | Phenylethanolamine N methyltransferase inhibitor | 0.043 0.024 DBMET01344 0.038 0.034 DBMET01349 0.041 0.028 DBMET01347 | DBMET01344 | |
| 0.044 | 0.033 | 0.044 | CDK7/cyclin H inhibitor | |||
| 0.073 | 0.062 | 0.194 | Metalloproteinase-2 inhibitor | 0.182 0.012 DBMET01338 0.084 0.049 DBMET01344 0.071 0.064 DBMET01349 0.194 0.011 DBMET01342 0.075 0.059 DBMET01346 0.076 0.057 DBMET01347 | DBMET01342 | |
| 0.061 | 0.05 | 0.216 | Neutrophil collagenase inhibitor | 0.178 0.009 DBMET01338 0.077 0.034 DBMET01344 0.216 0.007 DBMET01342 0.065 0.045 DBMET01346 0.064 0.046 DBMET01347 | DBMET01342 | |
| 0.099 | 0.09 | 0.099 | CDK3/cyclin E inhibitor | |||
| 0.023 | 0.014 | 0.028 | Estrone sulfatase inhibitor | 0.028 0.011 DBMET01349 0.021 0.015 DBMET01347 | DBMET01349 | |
| 0.05 | 0.043 | 0.118 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.048 0.046 DBMET01344 0.089 0.013 DBMET01349 0.05 0.043 DBMET01346 0.074 0.019 DBMET01347 0.118 0.008 DBMET01341 | DBMET01341 | |
| 0.016 | 0.011 | 0.016 | CDK2/cyclin A3 inhibitor | |||
| 0.087 | 0.082 | 0.107 | Urease inhibitor | 0.107 0.059 DBMET01349 0.09 0.079 DBMET01346 0.098 0.07 DBMET01341 | DBMET01349 | |
| 0.044 | 0.039 | 0.044 | Mineralocorticoid receptor antagonist | |||
| 0.017 | 0.012 | 0.024 | Carbonic anhydrase VIII inhibitor | 0.015 0.014 DBMET01344 0.024 0.006 DBMET01346 | DBMET01346 | |
| 0.017 | 0.012 | 0.024 | Carbonic anhydrase X inhibitor | 0.015 0.014 DBMET01344 0.024 0.006 DBMET01346 | DBMET01346 | |
| 0.013 | 0.008 | 0.015 | Carbonic anhydrase XI inhibitor | 0.015 0.006 DBMET01346 0.012 0.011 DBMET01341 | DBMET01346 | |
| 0.101 | 0.096 | 0.178 | Estrogen antagonist | 0.178 0.016 DBMET01349 0.101 0.095 DBMET01346 0.149 0.024 DBMET01347 0.133 0.035 DBMET01341 | DBMET01349 | |
| 0.088 | 0.088 | 0.155 | Estrogen receptor beta antagonist | 0.155 0.014 DBMET01349 0.095 0.074 DBMET01340 0.093 0.077 DBMET01346 0.136 0.02 DBMET01347 0.135 0.02 DBMET01341 | DBMET01349 | |
| 0.057 | 0.058 | 0.057 | Trypsin inhibitor | 0.057 0.055 DBMET01346 | DBMET01346 | |
| 0.122 | 0.124 | 0.219 | Arachidonic acid antagonist | 0.146 0.093 DBMET01349 0.181 0.053 DBMET01340 0.129 0.114 DBMET01346 0.219 0.018 DBMET01341 | DBMET01341 | |
| 0.122 | 0.125 | 0.17 | Heat shock protein 90 alpha antagonist | 0.167 0.072 DBMET01349 0.17 0.07 DBMET01341 | DBMET01341 | |
| 0.031 | 0.035 | 0.042 | AMPA receptor agonist | 0.042 0.015 DBMET01346 | DBMET01346 | |
| 0.098 | 0.102 | 0.111 | Interleukin 8 antagonist | 0.111 0.075 DBMET01349 0.104 0.088 DBMET01346 | DBMET01349 | |
| 0.047 | 0.053 | 0.052 | Matrix metalloproteinase (membrane-type) inhibitor | 0.052 0.042 DBMET01344 | DBMET01344 | |
| 0.021 | 0.027 | 0.032 | Glutamate (mGluR1) agonist | 0.023 0.02 DBMET01340 0.032 0.009 DBMET01346 | DBMET01346 | |
| 0.034 | 0.041 | 0.062 | AMPA 4 receptor antagonist | 0.036 0.035 DBMET01344 0.062 0.01 DBMET01346 | DBMET01346 | |
| 0.011 | 0.021 | 0.016 | G-protein-coupled receptor 120 agonist | 0.016 0.013 DBMET01344 0.016 0.013 DBMET01346 | DBMET01346 | |
| 0.033 | 0.045 | 0.045 | Aggrecanase 1 inhibitor | 0.045 0.018 DBMET01338 0.042 0.023 DBMET01342 | DBMET01338 | |
| 0.035 | 0.048 | 0.039 | Sphingosine 1-phosphate receptor agonist | 0.039 0.038 DBMET01346 | DBMET01346 | |
| 0.124 | 0.136 | 0.163 | Amyloid beta precursor protein antagonist | 0.149 0.102 DBMET01344 0.15 0.101 DBMET01349 0.163 0.088 DBMET01347 | DBMET01347 | |
| 0.014 | 0.028 | 0.049 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.049 0.007 DBMET01349 0.028 0.013 DBMET01347 | DBMET01349 | |
| 0.061 | 0.078 | 0.157 | Metalloproteinase-9 inhibitor | 0.157 0.014 DBMET01338 0.144 0.017 DBMET01342 | DBMET01338 | |
| 0.019 | 0.039 | 0.048 | Calcium-sensing receptor agonist | 0.032 0.011 DBMET01346 0.048 0.005 DBMET01341 | DBMET01341 | |
| 0.044 | 0.072 | 0.12 | Sphingosine 1-phosphate receptor 3 antagonist | 0.12 0.005 DBMET01341 | DBMET01341 | |
| 0.013 | 0.047 | 0.034 | Kynurenine 3 monooxygenase inhibitor | 0.034 0.013 DBMET01346 | DBMET01346 | |
| 0.115 | 0.148 | 0.543 | Dual specificity phosphatase inhibitor | 0.155 0.089 DBMET01344 0.143 0.103 DBMET01349 0.202 0.053 DBMET01346 0.166 0.078 DBMET01347 0.543 0.005 DBMET01341 | DBMET01341 | |
| 0.021 | 0.056 | 0.074 | Farnesoid X receptor agonist | 0.074 0.006 DBMET01340 0.054 0.012 DBMET01346 | DBMET01340 | |
| 0.038 | 0.073 | 0.082 | Myc inhibitor | 0.05 0.045 DBMET01340 0.082 0.012 DBMET01341 | DBMET01341 | |
| 0.103 | 0.139 | 0.152 | Mannose-6-phosphate isomerase inhibitor | 0.152 0.063 DBMET01341 | DBMET01341 | |
| 0.163 | 0.2 | 0.424 | Hypoxia-inducible factor 1 alpha inhibitor | 0.237 0.113 DBMET01349 0.182 0.176 DBMET01347 0.424 0.025 DBMET01341 | DBMET01341 | |
| 0.168 | 0.205 | 0.197 | Tyrosine 3 hydroxylase inhibitor | 0.197 0.141 DBMET01349 | DBMET01349 | |
| 0.012 | 0.052 | 0.025 | Glutamate (mGluR1a) agonist | 0.025 0.012 DBMET01340 | DBMET01340 | |
| 0.017 | 0.059 | 0.057 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.057 0.012 DBMET01349 0.05 0.016 DBMET01347 | DBMET01349 | |
| 0.034 | 0.08 | 0.054 | Beta 1 adrenoreceptor antagonist | 0.054 0.042 DBMET01347 | DBMET01347 | |
| 0.06 | 0.105 | 0.094 | Estrogen receptor alpha antagonist | 0.094 0.031 DBMET01349 0.073 0.061 DBMET01347 0.075 0.058 DBMET01341 | DBMET01349 | |
| 0.07 | 0.115 | 0.177 | GABA C receptor agonist | 0.177 0.025 DBMET01346 | DBMET01346 | |
| 0.025 | 0.075 | 0.041 | Retinoid X receptor antagonist | 0.041 0.023 DBMET01346 | DBMET01346 | |
| 0.022 | 0.073 | 0.041 | Macrophage elastase inhibitor | 0.041 0.033 DBMET01338 0.04 0.034 DBMET01342 | DBMET01338 | |
| 0.022 | 0.074 | 0.035 | Retinoid X alpha receptor antagonist | 0.035 0.022 DBMET01346 | DBMET01346 | |
| 0.037 | 0.096 | 0.164 | Matrix metalloproteinase inhibitor | 0.146 0.014 DBMET01338 0.164 0.012 DBMET01342 | DBMET01342 | |
| 0.107 | 0.167 | 0.135 | Sphingosine 1-phosphate receptor 5 antagonist | 0.135 0.088 DBMET01346 | DBMET01346 | |
| 0.151 | 0.21 | 0.196 | Thyroid hormone antagonist | 0.196 0.165 DBMET01341 | DBMET01341 | |
| 0.057 | 0.118 | 0.209 | Aminopeptidase B inhibitor | 0.106 0.061 DBMET01346 0.209 0.019 DBMET01341 | DBMET01341 | |
| 0.028 | 0.09 | 0.049 | Beta 2 adrenoreceptor antagonist | 0.049 0.038 DBMET01347 | DBMET01347 | |
| 0.027 | 0.091 | 0.046 | AICAR transformylase inhibitor | 0.046 0.027 DBMET01341 | DBMET01341 | |
| 0.02 | 0.089 | 0.038 | Glutamate (mGluR3) antagonist | 0.038 0.023 DBMET01346 | DBMET01346 | |
| 0.092 | 0.161 | 0.172 | Mcl-1 antagonist | 0.135 0.106 DBMET01349 0.172 0.072 DBMET01346 0.123 0.122 DBMET01347 | DBMET01346 | |
| 0.174 | 0.245 | 0.263 | DNA polymerase beta inhibitor | 0.263 0.185 DBMET01341 | DBMET01341 | |
| 0.039 | 0.111 | 0.075 | NMDA receptor agonist | 0.057 0.052 DBMET01346 0.075 0.032 DBMET01341 | DBMET01341 | |
| 0.01 | 0.084 | 0.027 | AMPA 3 receptor antagonist | 0.027 0.023 DBMET01346 | DBMET01346 | |
| 0.048 | 0.124 | 0.103 | Macrophage migration inhibitory factor inhibitor | 0.095 0.038 DBMET01349 0.091 0.04 DBMET01347 0.103 0.033 DBMET01341 | DBMET01341 | |
| 0.038 | 0.117 | 0.061 | Beta adrenoreceptor antagonist | 0.061 0.054 DBMET01347 | DBMET01347 | |
| 0.054 | 0.133 | 0.27 | 5-Lipoxygenase inhibitor | 0.27 0.013 DBMET01338 0.109 0.057 DBMET01349 0.266 0.014 DBMET01342 0.111 0.056 DBMET01347 | DBMET01338 | |
| 0.044 | 0.125 | 0.06 | Beta 3 adrenoreceptor antagonist | 0.06 0.055 DBMET01347 | DBMET01347 | |
| 0.016 | 0.097 | 0.043 | Estradiol 17 beta-dehydrogenase inhibitor | 0.043 0.029 DBMET01349 | DBMET01349 | |
| 0.055 | 0.137 | 0.181 | Potassium channel activator | 0.181 0.012 DBMET01338 0.083 0.07 DBMET01342 0.082 0.072 DBMET01341 | DBMET01338 | |
| 0.048 | 0.132 | 0.065 | Glutamate (mGluR6) antagonist | 0.065 0.05 DBMET01346 | DBMET01346 | |
| 0.005 | 0.091 | 0.047 | Estrogen receptor alpha agonist | 0.047 0.018 DBMET01349 0.043 0.02 DBMET01347 | DBMET01349 | |
| 0.036 | 0.127 | 0.303 | Porphobilinogen synthase inhibitor | 0.08 0.047 DBMET01340 0.069 0.057 DBMET01346 0.303 0.005 DBMET01341 | DBMET01341 | |
| 0.161 | 0.253 | 0.264 | Alpha-glucosidase inhibitor | 0.264 0.179 DBMET01349 0.244 0.191 DBMET01347 | DBMET01349 | |
| 0.065 | 0.158 | 0.355 | GABA C receptor antagonist | 0.115 0.058 DBMET01340 0.355 0.004 DBMET01341 | DBMET01341 | |
| 0.136 | 0.231 | 0.226 | 12-Lipoxygenase inhibitor | 0.226 0.125 DBMET01349 0.214 0.137 DBMET01347 0.218 0.133 DBMET01341 | DBMET01349 | |
| 0.017 | 0.12 | 0.046 | Angiotensin AT1 receptor antagonist | 0.046 0.023 DBMET01338 0.045 0.024 DBMET01342 0.042 0.03 DBMET01341 | DBMET01338 | |
| 0.019 | 0.122 | 0.089 | Matrix metalloproteinase 1 inhibitor | 0.085 0.019 DBMET01338 0.089 0.017 DBMET01342 | DBMET01342 | |
| 0.098 | 0.207 | 0.237 | Insulin sensitizer | 0.237 0.043 DBMET01341 | DBMET01341 | |
| 0.086 | 0.196 | 0.153 | Hexokinase inhibitor | 0.153 0.075 DBMET01341 | DBMET01341 | |
| 0.057 | 0.168 | 0.097 | Bile acid receptor antagonist | 0.086 0.085 DBMET01340 0.097 0.056 DBMET01341 | DBMET01341 | |
| 0.066 | 0.184 | 0.099 | DOPA decarboxylase inhibitor | 0.098 0.08 DBMET01349 0.099 0.078 DBMET01346 0.095 0.086 DBMET01347 | DBMET01346 | |
| 0.014 | 0.144 | 0.032 | Angiotensin II receptor antagonist | 0.032 0.028 DBMET01338 0.031 0.03 DBMET01342 | DBMET01338 | |
| 0.01 | 0.14 | 0.075 | Estrogen agonist | 0.067 0.027 DBMET01349 0.045 0.039 DBMET01347 0.075 0.024 DBMET01341 | DBMET01341 | |
| 0.042 | 0.173 | 0.259 | Protein-tyrosine phosphatase 1B inhibitor | 0.12 0.064 DBMET01346 0.109 0.071 DBMET01347 0.259 0.015 DBMET01341 | DBMET01341 | |
| 0.085 | 0.217 | 0.212 | DNA methyltransferase I inhibitor | 0.212 0.063 DBMET01341 | DBMET01341 | |
| 0.008 | 0.147 | 0.026 | Lysophosphatidic acid 1 receptor antagonist | 0.026 0.009 DBMET01341 | DBMET01341 | |
| 0.013 | 0.151 | 0.066 | AMPA receptor antagonist | 0.051 0.031 DBMET01338 0.066 0.022 DBMET01342 | DBMET01342 | |
| 0.064 | 0.203 | 0.233 | Photosensitizer | 0.233 0.008 DBMET01341 | DBMET01341 | |
| 0.027 | 0.174 | 0.067 | Histidine decarboxylase inhibitor | 0.067 0.053 DBMET01347 | DBMET01347 | |
| 0.062 | 0.211 | 0.23 | Adenylate kinase inhibitor | 0.23 0.012 DBMET01341 | DBMET01341 | |
| 0.048 | 0.198 | 0.214 | Triose-phosphate isomerase inhibitor | 0.214 0.009 DBMET01341 | DBMET01341 | |
| 0.022 | 0.174 | 0.065 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.065 0.005 DBMET01341 | DBMET01341 | |
| 0.025 | 0.178 | 0.162 | Phenylalanine 4-hydroxylase inhibitor | 0.162 0.01 DBMET01341 | DBMET01341 | |
| 0.067 | 0.22 | 0.445 | Protein-tyrosine phosphatase inhibitor | 0.127 0.104 DBMET01344 0.158 0.071 DBMET01346 0.148 0.081 DBMET01347 0.445 0.006 DBMET01341 | DBMET01341 | |
| 0.03 | 0.19 | 0.153 | Purinergic P2X1 antagonist | 0.153 0.007 DBMET01341 | DBMET01341 | |
| 0.071 | 0.232 | 0.182 | Cell wall synthesis inhibitor | 0.182 0.039 DBMET01341 | DBMET01341 | |
| 0.095 | 0.256 | 0.288 | Succinate dehydrogenase inhibitor | 0.146 0.119 DBMET01340 0.148 0.116 DBMET01346 0.288 0.013 DBMET01341 | DBMET01341 | |
| 0.02 | 0.183 | 0.19 | Purinergic P2X2 antagonist | 0.19 0.005 DBMET01341 | DBMET01341 | |
| 0.023 | 0.186 | 0.065 | Glucose-6-phosphate isomerase inhibitor | 0.065 0.015 DBMET01341 | DBMET01341 | |
| 0.049 | 0.215 | 0.101 | Thioredoxin inhibitor | 0.089 0.063 DBMET01344 0.097 0.051 DBMET01347 0.101 0.047 DBMET01341 | DBMET01341 | |
| 0.041 | 0.21 | 0.109 | Creatine kinase inhibitor | 0.083 0.082 DBMET01349 0.084 0.081 DBMET01340 0.109 0.05 DBMET01341 | DBMET01341 | |
| 0.138 | 0.311 | 0.232 | Caspase 3 stimulant | 0.215 0.148 DBMET01349 0.232 0.13 DBMET01347 | DBMET01347 | |
| 0.078 | 0.251 | 0.139 | DNA repair enzyme inhibitor | 0.139 0.043 DBMET01341 | DBMET01341 | |
| 0.043 | 0.217 | 0.095 | Uric acid excretion stimulant | 0.084 0.075 DBMET01344 0.095 0.058 DBMET01346 0.094 0.059 DBMET01347 0.088 0.068 DBMET01341 | DBMET01346 | |
| 0.062 | 0.243 | 0.526 | Peroxidase inhibitor | 0.526 0.008 DBMET01341 | DBMET01341 | |
| 0.046 | 0.232 | 0.169 | NADH dehydrogenase inhibitor | 0.169 0.014 DBMET01341 | DBMET01341 | |
| 0.092 | 0.28 | 0.332 | Prostaglandin dehydrogenase inhibitor | 0.332 0.089 DBMET01341 | DBMET01341 | |
| 0.074 | 0.269 | 0.164 | DNA methylase inhibitor | 0.164 0.106 DBMET01341 | DBMET01341 | |
| 0.011 | 0.223 | 0.209 | Collagenase inhibitor | 0.209 0.003 DBMET01338 0.176 0.004 DBMET01342 | DBMET01338 | |
| 0.051 | 0.268 | 0.18 | Cathepsin H inhibitor | 0.18 0.029 DBMET01341 | DBMET01341 | |
| 0.117 | 0.338 | 0.249 | Insulysin inhibitor | 0.249 0.097 DBMET01341 | DBMET01341 | |
| 0.023 | 0.251 | 0.166 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.166 0.015 DBMET01341 | DBMET01341 | |
| 0.052 | 0.282 | 0.373 | Pyruvate kinase inhibitor | 0.373 0.027 DBMET01341 | DBMET01341 | |
| 0.015 | 0.244 | 0.126 | Phosphofructokinase-1 inhibitor | 0.126 0.024 DBMET01341 | DBMET01341 | |
| 0.014 | 0.245 | 0.064 | Lysophosphatidic acid 3 receptor antagonist | 0.064 0.019 DBMET01341 | DBMET01341 | |
| 0.022 | 0.253 | 0.047 | CF transmembrane conductance regulator antagonist | 0.047 0.012 DBMET01341 | DBMET01341 | |
| 0.032 | 0.265 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.053 DBMET01347 | DBMET01347 | |
| 0.028 | 0.261 | 0.128 | Alcohol dehydrogenase inhibitor | 0.128 0.029 DBMET01341 | DBMET01341 | |
| 0.034 | 0.27 | 0.257 | ErbB-3 antagonist | 0.257 0.005 DBMET01340 | DBMET01340 | |
| 0.011 | 0.265 | 0.042 | Purinergic P2X3 antagonist | 0.042 0.015 DBMET01341 | DBMET01341 | |
| 0.008 | 0.268 | 0.054 | Lysophosphatidic acid 2 receptor antagonist | 0.054 0.008 DBMET01341 | DBMET01341 | |
| 0.02 | 0.293 | 0.237 | CDC25A inhibitor | 0.066 0.064 DBMET01340 0.237 0.005 DBMET01341 | DBMET01341 | |
| 0.022 | 0.3 | 0.066 | Dihydroorotate oxidase inhibitor | 0.066 0.022 DBMET01341 | DBMET01341 | |
| 0.113 | 0.392 | 0.389 | Calcium channel activator | 0.389 0.029 DBMET01341 | DBMET01341 | |
| 0.045 | 0.33 | 0.121 | Phospholipase A2 inhibitor | 0.121 0.115 DBMET01341 | DBMET01341 | |
| 0.12 | 0.42 | 0.24 | Apoptosis agonist | 0.24 0.225 DBMET01349 0.24 0.226 DBMET01347 | DBMET01347 | |
| 0.003 | 0.32 | 0.028 | Uridine phosphorylase inhibitor | 0.028 0.019 DBMET01341 | DBMET01341 | |
| 0.079 | 0.404 | 0.268 | Antithrombotic | 0.268 0.112 DBMET01341 | DBMET01341 | |
| 0.031 | 0.357 | 0.121 | GABA B receptor agonist | 0.121 0.007 DBMET01341 | DBMET01341 | |
| 0.029 | 0.366 | 0.168 | HIV-1 integrase (Overall Integration) inhibitor | 0.168 0.02 DBMET01341 | DBMET01341 | |
| 0.004 | 0.344 | 0.05 | Squalene synthetase inhibitor | 0.05 0.014 DBMET01340 0.046 0.016 DBMET01341 | DBMET01340 | |
| 0.017 | 0.361 | 0.067 | Heparanase inhibitor | 0.067 0.014 DBMET01341 | DBMET01341 | |
| 0.006 | 0.357 | 0.419 | CYP24 inhibitor | 0.419 0.001 DBMET01340 | DBMET01340 | |
| 0.059 | 0.42 | 0.192 | Phospholipase C inhibitor | 0.192 0.05 DBMET01341 | DBMET01341 | |
| 0.072 | 0.438 | 0.226 | Gastrin inhibitor | 0.226 0.11 DBMET01341 | DBMET01341 | |
| 0.021 | 0.397 | 0.141 | GABA A receptor agonist | 0.141 0.017 DBMET01341 | DBMET01341 | |
| 0.073 | 0.452 | 0.172 | Neurotensin receptor agonist | 0.172 0.059 DBMET01341 | DBMET01341 | |
| 0.018 | 0.406 | 0.102 | Alkylator | 0.102 0.086 DBMET01341 | DBMET01341 | |
| 0.06 | 0.456 | 0.311 | Superoxide dismutase inhibitor | 0.311 0.047 DBMET01341 | DBMET01341 | |
| 0.024 | 0.428 | 0.221 | GABA receptor agonist | 0.221 0.014 DBMET01341 | DBMET01341 | |
| 0.008 | 0.414 | 0.101 | HIV-1 integrase (3'-Processing) inhibitor | 0.101 0.026 DBMET01341 | DBMET01341 | |
| 0.073 | 0.479 | 0.254 | RNA-directed DNA polymerase inhibitor | 0.254 0.047 DBMET01341 | DBMET01341 | |
| 0.007 | 0.435 | 0.044 | Mannosidase inhibitor | 0.044 0.033 DBMET01341 | DBMET01341 | |
| 0.007 | 0.437 | 0.1 | Follicle-stimulating hormone antagonist | 0.1 0.003 DBMET01341 | DBMET01341 | |
| 0.024 | 0.473 | 0.09 | Xanthine oxidase inhibitor | 0.09 0.072 DBMET01341 | DBMET01341 | |
| 0.008 | 0.47 | 0.053 | Purinergic P2X antagonist | 0.053 0.03 DBMET01341 | DBMET01341 | |
| 0.004 | 0.475 | 0.099 | Follicle-stimulating hormone agonist | 0.099 0.004 DBMET01341 | DBMET01341 | |
| 0.01 | 0.488 | 0.084 | Protein kinase C zeta inhibitor | 0.084 0.077 DBMET01341 | DBMET01341 | |
| 0.105 | 0.586 | 0.321 | Calcium channel L-type activator | 0.257 0.197 DBMET01344 0.321 0.14 DBMET01347 | DBMET01347 | |
| 0.017 | 0.523 | 0.14 | Protein kinase (CK1) gamma 3 inhibitor | 0.14 0.102 DBMET01341 | DBMET01341 | |
| 0.021 | 0.538 | 0.139 | Acetylcholine M1 receptor antagonist | 0.139 0.086 DBMET01341 | DBMET01341 | |
| 0.051 | 0.578 | 0.204 | Vasodilator, coronary | 0.204 0.179 DBMET01341 | DBMET01341 | |
| 0.012 | 0.542 | 0.109 | Mucolytic | 0.109 0.066 DBMET01341 | DBMET01341 | |
| 0.013 | 0.552 | 0.35 | Autotaxin inhibitor | 0.35 0.004 DBMET01341 | DBMET01341 | |
| 0.025 | 0.582 | 0.152 | Hemostatic | 0.152 0.065 DBMET01341 | DBMET01341 | |
| 0.009 | 0.574 | 0.192 | Purinergic P2Y2 antagonist | 0.037 0.019 DBMET01340 0.192 0.002 DBMET01341 | DBMET01341 | |
| 0.005 | 0.57 | 0.063 | HIV-1 integrase (Strand Transfer) inhibitor | 0.063 0.04 DBMET01341 | DBMET01341 | |
| 0.004 | 0.575 | 0.04 | Purinergic P2Y antagonist | 0.04 0.037 DBMET01341 | DBMET01341 | |
| 0.021 | 0.618 | 0.2 | DNA synthesis inhibitor | 0.2 0.123 DBMET01341 | DBMET01341 | |
| 0.029 | 0.649 | 0.493 | Antiobesity | 0.493 0.039 DBMET01340 | DBMET01340 | |
| 0.018 | 0.654 | 0.153 | Antiamyloidogenic | 0.153 0.144 DBMET01341 | DBMET01341 | |
| 0.022 | 0.679 | 0.167 | DNA damaging | 0.167 0.148 DBMET01341 | DBMET01341 | |
| 0.005 | 0.679 | 0.225 | Purinergic P2 antagonist | 0.225 0.005 DBMET01341 | DBMET01341 | |
| 0.005 | 0.711 | 0.378 | Neuraminidase (influenza) inhibitor | 0.378 0.002 DBMET01340 0.126 0.01 DBMET01346 0.072 0.032 DBMET01341 | DBMET01340 | |
| 0.004 | 0.755 | 0.391 | Neuraminidase inhibitor | 0.391 0.001 DBMET01340 0.102 0.015 DBMET01346 | DBMET01340 | |
| 0.032 | 0.792 | 0.197 | Apoptosis antagonist | 0.197 0.183 DBMET01347 | DBMET01347 | |
| 0.002 | 0.802 | 0.058 | Purinergic P2X agonist | 0.058 0.007 DBMET01341 | DBMET01341 | |
| 0.011 | 0.857 | 0.453 | Cyclophilin D inhibitor | 0.453 0.066 DBMET01340 | DBMET01340 | |
| 0.008 | 0.924 | 0.049 | Sodium/calcium exchanger inhibitor | 0.049 0.036 DBMET01341 | DBMET01341 | |
| 0.004 | 0.948 | 0.113 | Lipid peroxidase inhibitor | 0.113 0.101 DBMET01341 | DBMET01341 | |
| 0.006 | 0.977 | 0.138 | Histone deacetylase SIRT1 inhibitor | 0.138 0.073 DBMET01341 | DBMET01341 | |
| 0.003 | 0.981 | 0.058 | Neuraminidase (Influenza A) inhibitor | 0.058 0.014 DBMET01346 | DBMET01346 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |